Mark Iwicki
Patrimonio netto: - $ in data 31/05/2026
Patrimonio netto: - $ in data 31/05/2026
Mark T. Iwicki è presidente di Q32 Bio, Inc., presidente di Akero Therapeutics, Inc., direttore indipendente di Pulmatrix, Inc., direttore non esecutivo indipendente di Merus NV, presidente, presidente e amministratore delegato di Kala Pharmaceuticals, Inc. e direttore indipendente di Aimmune Therapeutics, Inc. Fa parte del consiglio di amministrazione di Pulmatrix, Inc., Merus NV, Nimbus Therapeutics LLC, Aimmune Therapeutics, Inc., Nimbus Apollo, Inc., Oxeia Biopharmaceuticals, Inc. e Pulmatrix Operating Co. Iwicki è stato precedentemente impiegato come presidente, amministratore delegato e direttore di Civitas Therapeutics, Inc., presidente, amministratore delegato e direttore di Blend Therapeutics, Inc., presidente e amministratore delegato di Sepracor Pharmaceuticals Inc, vicepresidente di Novartis Pharmaceuticals Corp, un vicepresidente e responsabile della business unit cardiovascolare di Novartis Pharmaceuticals UK Ltd., un direttore di Astra Merck, Inc., un direttore di Merck & Co., Inc. e un presidente e amministratore delegato di Sumitomo Dainippon Pharma Co. Ha anche fatto parte del consiglio di amministrazione di TARIS BioMedical LLC e della Wellesley Youth Hockey Association. Ha conseguito la laurea presso la Ball State University (Indiana) e un MBA presso la Loyola University Maryland, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 29/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
-.--% | 12/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Presidente | 01/05/2020 |
| INHIBIKASE THERAPEUTICS, INC. | Amministratore Delegato | 14/02/2025 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consulente / Consigliere | - |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Presidente | 22/12/2020 |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Direttore/Membro del Consiglio | - |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| KALA BIO, INC. | Amministratore Delegato | 11/02/2025 |
| MERUS N.V. | Presidente | 01/07/2018 |
| AKERO THERAPEUTICS, INC. | Presidente | 09/12/2025 |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 26 |
|---|---|
Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and other chemical products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Kala Bio, Inc.
Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biotechnology company which develops therapeutics for mild traumatic brain injuries and neuro-metabolic dysfunctions | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Ball State University (Indiana)
Ball State University (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University Maryland, Inc.
Loyola University Maryland, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Pulmatrix, Inc.
Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Wellesley Youth Hockey Association
Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Operates as an association for the improvement of hockey | Consumer Services |
Akero Therapeutics, Inc.
Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale